Anika Therapeutics (ANIK) Goodwill & Intangibles (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Goodwill & Intangibles data on file, last reported at $9.5 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 4.59% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 4.59% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 25.62% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $9.5 million, down from $9.7 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for ANIK reached as high as $119.8 million in Q1 2022 and fell as low as $7.7 million in Q4 2024.
• Historically, Goodwill & Intangibles has averaged $57.0 million across 5 years, with a median of $23.8 million in 2025.
• Across the five-year window, Goodwill & Intangibles slumped 91.51% in 2023 and soared 110.2% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $119.5 million in 2022, then slumped by 91.51% to $10.1 million in 2023, then dropped by 23.87% to $7.7 million in 2024, then advanced by 25.62% to $9.7 million in 2025, then retreated by 1.67% to $9.5 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $9.5 million in Q1 2026, $9.7 million in Q4 2025, and $23.8 million in Q3 2025.